Clinical Study of an Ultrasound Renal Denervation System in Patients With Heart Failure

NCT04719637 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2026-03-17

No results posted yet for this study

Summary

The purpose is to evaluate the renal denervation system (PRDS-001) for controlling sympathetic nerve over-activation in patients with heart failure, and for its safety in such patients.

Conditions

Interventions

DEVICE

PRDS-001 Renal Denervation Ultrasound System

Renal Denervation Ultrasound System

Sponsors & Collaborators

  • Otsuka Medical Devices Co., Ltd. Japan

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-24
Primary Completion
2022-02-16
Completion
2024-08-07

Countries

  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04719637 on ClinicalTrials.gov